This article is part of the supplement: Proceedings of the 8th Global Arthritis Research Network (GARN) Meeting and 1st Bio-Rheumatology International Congress (BRIC)

Poster presentation

Age features of metabolic syndrome and cardiovascular disorders in gout

Surayo Shukurova*, Khisrav Toirov, Nabijon Hamidov and Dilfuza Jonnazarova

  • * Corresponding author: Surayo Shukurova

Author Affiliations

AvicennaTajik State Medical University, Tajikistan

For all author emails, please log on.

Arthritis Research & Therapy 2012, 14(Suppl 1):P69 doi:10.1186/ar3670


The electronic version of this article is the complete one and can be found online at: http://arthritis-research.com/content/14/S1/P69


Published:9 February 2012

© 2012 Shukurova et al.; licensee BioMed Central Ltd.

Materials and methods

Are surveyed 76 gout patients, middle age equaled 56.6 ± 7.5 year. Have been distributed on 3 groups: more younger 50, from 50 to 60 and more senior 60 years. Metabolic syndrome was diagnosed by criteria Adult Treatment Panel III (National Institute of Health, USA) [1]. Serum level of Uric Acid defined by colorimetric enzyme method, glucose - by glucose oxidize method, cholesterol, triglycerides and high density lipoproteides-cholesterol - by colorimetric method [2]. Low and very low density lipoproteides-cholesterol defined by "WT Friedewald Equation" (1972) [3].

Results

Metabolic syndrome has been diagnosed at 46 (60.5%) patients. Middle age patients with presence of metabolic syndrome has made 55.7 ± 4.7, without - 57.9 ± 8.3 year.

Conclusions

At the same time we have not revealed age distinctions in occurrence of metabolic syndrome at patients with primary gout, however frequency of IHD of gout patients naturally increased with the years - from 38% to 68%. Patients of the senior age groups the increase in frequency of hypertension and IHD while patients of younger age have obesity, hypertriglyceridemia and hyperglycemia is more often noted.

Table 1. Frequency of revealing of signs of metabolic syndrome at gout patients (n = 76)

Table 2. Frequency of revealing of signs metabolic syndrome at gout patients depending on age, n (%)

Acknowledgements

Research grants were received from APLAR.

References

  1. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

    JAMA 2001, 285(19):2486-2497. PubMed Abstract | Publisher Full Text OpenURL

  2. Rifai N, Bachorik PS, Albers JJ: Lipids, lipoproteins and apolipoproteins. In Tietz Textbook of Clinical Chemistry. 3rd edition. Edited by Burtis CA, Ashwood ER. Philadelphia: W.B. Saunders Company; 1999:809-861. OpenURL

  3. Friedewald WT, Levy RS, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

    Clin Chem 1972, 18:499-502. PubMed Abstract | Publisher Full Text OpenURL